JP2008520637A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008520637A5 JP2008520637A5 JP2007542103A JP2007542103A JP2008520637A5 JP 2008520637 A5 JP2008520637 A5 JP 2008520637A5 JP 2007542103 A JP2007542103 A JP 2007542103A JP 2007542103 A JP2007542103 A JP 2007542103A JP 2008520637 A5 JP2008520637 A5 JP 2008520637A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- phenoxy
- piperazinyl
- acetic acid
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 30
- 229910052736 halogen Inorganic materials 0.000 claims description 29
- 150000002367 halogens Chemical class 0.000 claims description 29
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 150000001875 compounds Chemical class 0.000 claims description 19
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- 239000001257 hydrogen Substances 0.000 claims description 17
- 125000001424 substituent group Chemical group 0.000 claims description 17
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 125000003118 aryl group Chemical group 0.000 claims description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 12
- 125000001072 heteroaryl group Chemical group 0.000 claims description 12
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 7
- -1 C (O) R 9 Chemical group 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- IXGJAVNJRRZJCZ-UHFFFAOYSA-N 2-[2-[4-(benzenesulfonyl)piperazin-1-yl]-4-chlorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1N1CCN(S(=O)(=O)C=2C=CC=CC=2)CC1 IXGJAVNJRRZJCZ-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 3
- FYBIPFSMDCQHGL-INIZCTEOSA-N 2-[2-[[(3s)-4-benzylsulfonyl-3-methylpiperazin-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound C([C@@H](N(CC1)S(=O)(=O)CC=2C=CC=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O FYBIPFSMDCQHGL-INIZCTEOSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 9
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 8
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- GMFBGMFMMAVODH-INIZCTEOSA-N 2-[4-chloro-2-[[(3s)-3-methyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O GMFBGMFMMAVODH-INIZCTEOSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- RRWLYFAHCPGELC-HNNXBMFYSA-N (2s)-2-[2-[(4-benzyl-3-oxopiperazin-1-yl)methyl]-4-chlorophenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1CN1CC(=O)N(CC=2C=CC=CC=2)CC1 RRWLYFAHCPGELC-HNNXBMFYSA-N 0.000 claims 1
- YMRIXJPQOSNAOM-INIZCTEOSA-N (2s)-2-[2-[(4-benzylsulfonylpiperazin-1-yl)methyl]-4-fluorophenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(F)C=C1CN1CCN(S(=O)(=O)CC=2C=CC=CC=2)CC1 YMRIXJPQOSNAOM-INIZCTEOSA-N 0.000 claims 1
- HCLYNTYHESHSGT-HNNXBMFYSA-N (2s)-2-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-4-fluorophenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(F)C=C1CN1CCN(S(=O)(=O)C=2C=CC=CC=2)CC1 HCLYNTYHESHSGT-HNNXBMFYSA-N 0.000 claims 1
- FWYQUEFNBWXQDJ-GJZGRUSLSA-N (2s)-2-[4-chloro-2-[(3s)-4-[2-(4-chlorophenyl)acetyl]-3-methylpiperazin-1-yl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1N1C[C@H](C)N(C(=O)CC=2C=CC(Cl)=CC=2)CC1 FWYQUEFNBWXQDJ-GJZGRUSLSA-N 0.000 claims 1
- SAJAASZXTYEPFC-GJZGRUSLSA-N (2s)-2-[4-chloro-2-[(3s)-4-[2-(4-fluorophenyl)acetyl]-3-methylpiperazin-1-yl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1N1C[C@H](C)N(C(=O)CC=2C=CC(F)=CC=2)CC1 SAJAASZXTYEPFC-GJZGRUSLSA-N 0.000 claims 1
- XPLZJCKZIQZDEA-IRXDYDNUSA-N (2s)-2-[4-chloro-2-[[(3s)-3-methyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1CN1C[C@H](C)N(C(=O)CC=2C=CC=CC=2)CC1 XPLZJCKZIQZDEA-IRXDYDNUSA-N 0.000 claims 1
- HAKFTQCBZVTOQD-ROUUACIJSA-N (2s)-2-[4-chloro-2-[[(3s)-3-methyl-4-[2-(4-methylphenyl)acetyl]piperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1CN1C[C@H](C)N(C(=O)CC=2C=CC(C)=CC=2)CC1 HAKFTQCBZVTOQD-ROUUACIJSA-N 0.000 claims 1
- BVOOUBNJHVCDSK-OALUTQOASA-N (2s)-2-[4-chloro-2-[[(3s)-3-methyl-4-[2-(4-propan-2-ylphenyl)acetyl]piperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound C1=CC(C(C)C)=CC=C1CC(=O)N1[C@@H](C)CN(CC=2C(=CC=C(Cl)C=2)O[C@@H](C)C(O)=O)CC1 BVOOUBNJHVCDSK-OALUTQOASA-N 0.000 claims 1
- BSPBODBNPCPHLA-HOTGVXAUSA-N (2s)-2-[4-chloro-2-[[(3s)-3-methyl-4-[2-[4-(trifluoromethyl)phenyl]acetyl]piperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1CN1C[C@H](C)N(C(=O)CC=2C=CC(=CC=2)C(F)(F)F)CC1 BSPBODBNPCPHLA-HOTGVXAUSA-N 0.000 claims 1
- GMXLSOTXSJJEGA-GJZGRUSLSA-N (2s)-2-[4-chloro-2-[[(3s)-4-[2-(2,4-dichlorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1CN1C[C@H](C)N(C(=O)CC=2C(=CC(Cl)=CC=2)Cl)CC1 GMXLSOTXSJJEGA-GJZGRUSLSA-N 0.000 claims 1
- NFWJBPHMYAFTNG-GJZGRUSLSA-N (2s)-2-[4-chloro-2-[[(3s)-4-[2-(3,4-dichlorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1CN1C[C@H](C)N(C(=O)CC=2C=C(Cl)C(Cl)=CC=2)CC1 NFWJBPHMYAFTNG-GJZGRUSLSA-N 0.000 claims 1
- CKABBNCZGDZGAN-GJZGRUSLSA-N (2s)-2-[4-chloro-2-[[(3s)-4-[2-(4-chloro-2-fluorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1CN1C[C@H](C)N(C(=O)CC=2C(=CC(Cl)=CC=2)F)CC1 CKABBNCZGDZGAN-GJZGRUSLSA-N 0.000 claims 1
- NOEKELZJHSRSCX-IRXDYDNUSA-N (2s)-2-[4-chloro-2-[[(3s)-4-[2-(4-methoxyphenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound C1=CC(OC)=CC=C1CC(=O)N1[C@@H](C)CN(CC=2C(=CC=C(Cl)C=2)O[C@@H](C)C(O)=O)CC1 NOEKELZJHSRSCX-IRXDYDNUSA-N 0.000 claims 1
- DKGIDOYCDBRQFD-GJZGRUSLSA-N (2s)-2-[4-chloro-2-[[(3s)-4-[2-[2-fluoro-4-(trifluoromethyl)phenyl]acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(Cl)C=C1CN1C[C@H](C)N(C(=O)CC=2C(=CC(=CC=2)C(F)(F)F)F)CC1 DKGIDOYCDBRQFD-GJZGRUSLSA-N 0.000 claims 1
- ZFHRZQDJPFXIRE-INIZCTEOSA-N (2s)-2-[4-fluoro-2-[[4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]propanoic acid Chemical compound OC(=O)[C@H](C)OC1=CC=C(F)C=C1CN1CCN(C(=O)CC=2C=CC=CC=2)CC1 ZFHRZQDJPFXIRE-INIZCTEOSA-N 0.000 claims 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- FQUYSHZXSKYCSY-UHFFFAOYSA-N 1,4-diazepane Chemical compound C1CNCCNC1 FQUYSHZXSKYCSY-UHFFFAOYSA-N 0.000 claims 1
- VTDIWMPYBAVEDY-UHFFFAOYSA-N 1-propylpiperidine Chemical compound CCCN1CCCCC1 VTDIWMPYBAVEDY-UHFFFAOYSA-N 0.000 claims 1
- SXJOQQNGWCJIHX-UHFFFAOYSA-N 2-[2-(4-benzylsulfonylpiperazin-1-yl)-4-chlorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1N1CCN(S(=O)(=O)CC=2C=CC=CC=2)CC1 SXJOQQNGWCJIHX-UHFFFAOYSA-N 0.000 claims 1
- ORSWDXYDKIPVGD-UHFFFAOYSA-N 2-[2-[(4-benzoyl-3-methylpiperazin-1-yl)methyl]-4-chlorophenoxy]acetic acid Chemical compound C1CN(C(=O)C=2C=CC=CC=2)C(C)CN1CC1=CC(Cl)=CC=C1OCC(O)=O ORSWDXYDKIPVGD-UHFFFAOYSA-N 0.000 claims 1
- OBMZISABHBNQKD-UHFFFAOYSA-N 2-[2-[(4-benzoylpiperazin-1-yl)methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1CN1CCN(C(=O)C=2C=CC=CC=2)CC1 OBMZISABHBNQKD-UHFFFAOYSA-N 0.000 claims 1
- FSYMRBYJPOBPII-UHFFFAOYSA-N 2-[2-[(4-benzylsulfonyl-1,4-diazepan-1-yl)methyl]-4-chlorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)CC=2C=CC=CC=2)CCC1 FSYMRBYJPOBPII-UHFFFAOYSA-N 0.000 claims 1
- SRIBGUFBFRUANK-UHFFFAOYSA-N 2-[2-[(4-benzylsulfonyl-2-methylpiperazin-1-yl)methyl]-4-chlorophenoxy]acetic acid Chemical compound CC1CN(S(=O)(=O)CC=2C=CC=CC=2)CCN1CC1=CC(Cl)=CC=C1OCC(O)=O SRIBGUFBFRUANK-UHFFFAOYSA-N 0.000 claims 1
- FYBIPFSMDCQHGL-UHFFFAOYSA-N 2-[2-[(4-benzylsulfonyl-3-methylpiperazin-1-yl)methyl]-4-chlorophenoxy]acetic acid Chemical compound C1CN(S(=O)(=O)CC=2C=CC=CC=2)C(C)CN1CC1=CC(Cl)=CC=C1OCC(O)=O FYBIPFSMDCQHGL-UHFFFAOYSA-N 0.000 claims 1
- JBBOMVFXXYZQQP-UHFFFAOYSA-N 2-[2-[(4-benzylsulfonylpiperazin-1-yl)methyl]-4-chlorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)CC=2C=CC=CC=2)CC1 JBBOMVFXXYZQQP-UHFFFAOYSA-N 0.000 claims 1
- WLFOCYYTIVOUSE-UHFFFAOYSA-N 2-[2-[(4-benzylsulfonylpiperazin-1-yl)methyl]-4-fluorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(F)C=C1CN1CCN(S(=O)(=O)CC=2C=CC=CC=2)CC1 WLFOCYYTIVOUSE-UHFFFAOYSA-N 0.000 claims 1
- YFYBEPKDKMHPHF-UHFFFAOYSA-N 2-[2-[1-[4-(benzenesulfonyl)piperazin-1-yl]ethyl]-4-chlorophenoxy]acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C(Cl)=CC=C(OCC(O)=O)C=1C(C)N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1 YFYBEPKDKMHPHF-UHFFFAOYSA-N 0.000 claims 1
- WENXBDQAWPNUHF-UHFFFAOYSA-N 2-[2-[4-(4-fluorophenyl)sulfonylpiperazin-1-yl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1N1CCN(S(=O)(=O)C=2C=CC(F)=CC=2)CC1 WENXBDQAWPNUHF-UHFFFAOYSA-N 0.000 claims 1
- YLPKAFLLNDMZDA-UHFFFAOYSA-N 2-[2-[[(1-benzylsulfonylpyrrolidin-3-yl)amino]methyl]-4-chlorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CNC1CN(S(=O)(=O)CC=2C=CC=CC=2)CC1 YLPKAFLLNDMZDA-UHFFFAOYSA-N 0.000 claims 1
- KQVTZYFUHDWJOQ-OAHLLOKOSA-N 2-[2-[[(2r)-4-(benzenesulfonyl)-2-methylpiperazin-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound C([C@H]1C)N(S(=O)(=O)C=2C=CC=CC=2)CCN1CC1=CC(Cl)=CC=C1OCC(O)=O KQVTZYFUHDWJOQ-OAHLLOKOSA-N 0.000 claims 1
- OVNWHOGUZJEKAS-OAHLLOKOSA-N 2-[2-[[(3r)-4-(benzenesulfonyl)-3-methylpiperazin-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound C([C@H](N(CC1)S(=O)(=O)C=2C=CC=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O OVNWHOGUZJEKAS-OAHLLOKOSA-N 0.000 claims 1
- FYBIPFSMDCQHGL-MRXNPFEDSA-N 2-[2-[[(3r)-4-benzylsulfonyl-3-methylpiperazin-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound C([C@H](N(CC1)S(=O)(=O)CC=2C=CC=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O FYBIPFSMDCQHGL-MRXNPFEDSA-N 0.000 claims 1
- ZIZVDEBHXJKPLF-INIZCTEOSA-N 2-[2-[[(3s)-3-methyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC=CC=2)C)N1CC1=CC(C(F)(F)F)=CC=C1OCC(O)=O ZIZVDEBHXJKPLF-INIZCTEOSA-N 0.000 claims 1
- RYDKHFBYSXPMIC-SFHVURJKSA-N 2-[2-[[(3s)-4-(benzenesulfonyl)-3-ethylpiperazin-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound C([C@@H](N(CC1)S(=O)(=O)C=2C=CC=CC=2)CC)N1CC1=CC(Cl)=CC=C1OCC(O)=O RYDKHFBYSXPMIC-SFHVURJKSA-N 0.000 claims 1
- SNMDUARWLPWWOD-INIZCTEOSA-N 2-[2-[[(3s)-4-(benzenesulfonyl)-3-methylpiperazin-1-yl]methyl]-4-chlorophenoxy]-2-methylpropanoic acid Chemical compound C([C@@H](N(CC1)S(=O)(=O)C=2C=CC=CC=2)C)N1CC1=CC(Cl)=CC=C1OC(C)(C)C(O)=O SNMDUARWLPWWOD-INIZCTEOSA-N 0.000 claims 1
- OVNWHOGUZJEKAS-HNNXBMFYSA-N 2-[2-[[(3s)-4-(benzenesulfonyl)-3-methylpiperazin-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound C([C@@H](N(CC1)S(=O)(=O)C=2C=CC=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O OVNWHOGUZJEKAS-HNNXBMFYSA-N 0.000 claims 1
- SZXBYKZAJAJDDC-IBGZPJMESA-N 2-[2-[[(3s)-4-(benzenesulfonyl)-3-propylpiperazin-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound C([C@@H](N(CC1)S(=O)(=O)C=2C=CC=CC=2)CCC)N1CC1=CC(Cl)=CC=C1OCC(O)=O SZXBYKZAJAJDDC-IBGZPJMESA-N 0.000 claims 1
- TWPPHHVXBDKGSK-HNNXBMFYSA-N 2-[2-[[(3s)-4-[2-(4-fluorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC(F)=CC=2)C)N1CC1=CC(C(F)(F)F)=CC=C1OCC(O)=O TWPPHHVXBDKGSK-HNNXBMFYSA-N 0.000 claims 1
- FLIBQBISMSABGY-UHFFFAOYSA-N 2-[2-[[4-(2-fluorophenyl)sulfonylpiperazin-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1CN1CCN(S(=O)(=O)C=2C(=CC=CC=2)F)CC1 FLIBQBISMSABGY-UHFFFAOYSA-N 0.000 claims 1
- HAOLKUKLONSUFT-UHFFFAOYSA-N 2-[2-[[4-(2-methylphenyl)sulfonylpiperazin-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)N1CCN(CC=2C(=CC=C(C=2)C(F)(F)F)OCC(O)=O)CC1 HAOLKUKLONSUFT-UHFFFAOYSA-N 0.000 claims 1
- ULOFDAOEEZQONI-UHFFFAOYSA-N 2-[2-[[4-(2-phenylacetyl)piperazin-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1CN1CCN(C(=O)CC=2C=CC=CC=2)CC1 ULOFDAOEEZQONI-UHFFFAOYSA-N 0.000 claims 1
- BZSFCWBYHPUSIP-UHFFFAOYSA-N 2-[2-[[4-(2-thiophen-2-ylacetyl)piperazin-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1CN1CCN(C(=O)CC=2SC=CC=2)CC1 BZSFCWBYHPUSIP-UHFFFAOYSA-N 0.000 claims 1
- HBHJUOTUSQCINC-UHFFFAOYSA-N 2-[2-[[4-(4-cyanophenyl)sulfonyl-1,4-diazepan-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1CN1CCN(S(=O)(=O)C=2C=CC(=CC=2)C#N)CCC1 HBHJUOTUSQCINC-UHFFFAOYSA-N 0.000 claims 1
- NICXRKSDXYULRK-UHFFFAOYSA-N 2-[2-[[4-(4-fluorophenyl)sulfonyl-1,4-diazepan-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1CN1CCN(S(=O)(=O)C=2C=CC(F)=CC=2)CCC1 NICXRKSDXYULRK-UHFFFAOYSA-N 0.000 claims 1
- LSKNVKUQIOUJKU-UHFFFAOYSA-N 2-[2-[[4-(4-nitrophenyl)sulfonylpiperazin-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1CN1CCN(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)CC1 LSKNVKUQIOUJKU-UHFFFAOYSA-N 0.000 claims 1
- QLFDFEFQMOQFGD-UHFFFAOYSA-N 2-[2-[[4-(benzenesulfonyl)-1,4-diazepan-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1CN1CCN(S(=O)(=O)C=2C=CC=CC=2)CCC1 QLFDFEFQMOQFGD-UHFFFAOYSA-N 0.000 claims 1
- QPKLSOHWYXCVTB-UHFFFAOYSA-N 2-[2-[[4-(benzenesulfonyl)-1,4-diazepan-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=CC=CC=2)CCC1 QPKLSOHWYXCVTB-UHFFFAOYSA-N 0.000 claims 1
- KQVTZYFUHDWJOQ-UHFFFAOYSA-N 2-[2-[[4-(benzenesulfonyl)-2-methylpiperazin-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound CC1CN(S(=O)(=O)C=2C=CC=CC=2)CCN1CC1=CC(Cl)=CC=C1OCC(O)=O KQVTZYFUHDWJOQ-UHFFFAOYSA-N 0.000 claims 1
- OVNWHOGUZJEKAS-UHFFFAOYSA-N 2-[2-[[4-(benzenesulfonyl)-3-methylpiperazin-1-yl]methyl]-4-chlorophenoxy]acetic acid Chemical compound C1CN(S(=O)(=O)C=2C=CC=CC=2)C(C)CN1CC1=CC(Cl)=CC=C1OCC(O)=O OVNWHOGUZJEKAS-UHFFFAOYSA-N 0.000 claims 1
- MNRULTNYMVKEMA-UHFFFAOYSA-N 2-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(C(F)(F)F)C=C1CN1CCN(S(=O)(=O)C=2C=CC=CC=2)CC1 MNRULTNYMVKEMA-UHFFFAOYSA-N 0.000 claims 1
- SNWISXHDGOBZCF-UHFFFAOYSA-N 2-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-4-fluorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(F)C=C1CN1CCN(S(=O)(=O)C=2C=CC=CC=2)CC1 SNWISXHDGOBZCF-UHFFFAOYSA-N 0.000 claims 1
- COQXOABONQWPHS-UHFFFAOYSA-N 2-[2-[[4-(benzenesulfonyl)piperazin-1-yl]methyl]-4-propan-2-ylphenoxy]acetic acid Chemical compound CC(C)C1=CC=C(OCC(O)=O)C(CN2CCN(CC2)S(=O)(=O)C=2C=CC=CC=2)=C1 COQXOABONQWPHS-UHFFFAOYSA-N 0.000 claims 1
- ZMNFGTRQTBDMOW-UHFFFAOYSA-N 2-[2-[[[1-(benzenesulfonyl)pyrrolidin-3-yl]-methylamino]methyl]-4-chlorophenoxy]acetic acid Chemical compound C1CN(S(=O)(=O)C=2C=CC=CC=2)CC1N(C)CC1=CC(Cl)=CC=C1OCC(O)=O ZMNFGTRQTBDMOW-UHFFFAOYSA-N 0.000 claims 1
- DJERRLOJXBPOPO-UHFFFAOYSA-N 2-[2-[[[1-(benzenesulfonyl)pyrrolidin-3-yl]amino]methyl]-4-chlorophenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CNC1CN(S(=O)(=O)C=2C=CC=CC=2)CC1 DJERRLOJXBPOPO-UHFFFAOYSA-N 0.000 claims 1
- KTAAWZKEPNPWTK-UHFFFAOYSA-N 2-[3-chloro-2-[[4-[2-(4-chlorophenyl)acetyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC(Cl)=C1CN1CCN(C(=O)CC=2C=CC(Cl)=CC=2)CC1 KTAAWZKEPNPWTK-UHFFFAOYSA-N 0.000 claims 1
- HXEJGACBYOEVOX-HNNXBMFYSA-N 2-[3-methyl-2-[(3s)-3-methyl-4-(2-phenylacetyl)piperazin-1-yl]-4-(trifluoromethyl)phenoxy]acetic acid Chemical compound C([C@@H]1C)N(C=2C(=CC=C(C=2C)C(F)(F)F)OCC(O)=O)CCN1C(=O)CC1=CC=CC=C1 HXEJGACBYOEVOX-HNNXBMFYSA-N 0.000 claims 1
- KZWUJVNNRAMFCJ-UHFFFAOYSA-N 2-[4-chloro-2-[4-(2-phenylacetyl)piperazin-1-yl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1N1CCN(C(=O)CC=2C=CC=CC=2)CC1 KZWUJVNNRAMFCJ-UHFFFAOYSA-N 0.000 claims 1
- GMFBGMFMMAVODH-MRXNPFEDSA-N 2-[4-chloro-2-[[(3r)-3-methyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@H](N(CC1)C(=O)CC=2C=CC=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O GMFBGMFMMAVODH-MRXNPFEDSA-N 0.000 claims 1
- WPTNBMSBMRYYKO-FQEVSTJZSA-N 2-[4-chloro-2-[[(3s)-3-ethyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC=CC=2)CC)N1CC1=CC(Cl)=CC=C1OCC(O)=O WPTNBMSBMRYYKO-FQEVSTJZSA-N 0.000 claims 1
- YUXPRRHTMUOHMI-KRWDZBQOSA-N 2-[4-chloro-2-[[(3s)-3-methyl-4-[2-(4-methylphenyl)acetyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC(C)=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O YUXPRRHTMUOHMI-KRWDZBQOSA-N 0.000 claims 1
- VIFCTABXRRMWCE-HNNXBMFYSA-N 2-[4-chloro-2-[[(3s)-3-methyl-4-[2-[4-(trifluoromethoxy)phenyl]acetyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC(OC(F)(F)F)=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O VIFCTABXRRMWCE-HNNXBMFYSA-N 0.000 claims 1
- ULQJVTFUHXKALQ-HNNXBMFYSA-N 2-[4-chloro-2-[[(3s)-3-methyl-4-[2-[4-(trifluoromethyl)phenyl]acetyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC(=CC=2)C(F)(F)F)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O ULQJVTFUHXKALQ-HNNXBMFYSA-N 0.000 claims 1
- PFXOFTISOIWABY-OAQYLSRUSA-N 2-[4-chloro-2-[[(3s)-4-(2-phenylacetyl)-3-propan-2-ylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC=CC=2)C(C)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O PFXOFTISOIWABY-OAQYLSRUSA-N 0.000 claims 1
- LRZJRQDAHZPEFU-NRFANRHFSA-N 2-[4-chloro-2-[[(3s)-4-(2-phenylacetyl)-3-propylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC=CC=2)CCC)N1CC1=CC(Cl)=CC=C1OCC(O)=O LRZJRQDAHZPEFU-NRFANRHFSA-N 0.000 claims 1
- LVRRECMHGPOQTQ-AWEZNQCLSA-N 2-[4-chloro-2-[[(3s)-4-[2-(2,4-dichlorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C(=CC(Cl)=CC=2)Cl)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O LVRRECMHGPOQTQ-AWEZNQCLSA-N 0.000 claims 1
- QGRXYDKCNSWGEB-AWEZNQCLSA-N 2-[4-chloro-2-[[(3s)-4-[2-(2,4-difluorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C(=CC(F)=CC=2)F)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O QGRXYDKCNSWGEB-AWEZNQCLSA-N 0.000 claims 1
- KVMMUHZNDVGFAI-HNNXBMFYSA-N 2-[4-chloro-2-[[(3s)-4-[2-(2-chlorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C(=CC=CC=2)Cl)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O KVMMUHZNDVGFAI-HNNXBMFYSA-N 0.000 claims 1
- BRNHNKARNMEPCH-AWEZNQCLSA-N 2-[4-chloro-2-[[(3s)-4-[2-(3,4-dichlorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=C(Cl)C(Cl)=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O BRNHNKARNMEPCH-AWEZNQCLSA-N 0.000 claims 1
- AKGCSSSQGMHLQE-HNNXBMFYSA-N 2-[4-chloro-2-[[(3s)-4-[2-(3-chlorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=C(Cl)C=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O AKGCSSSQGMHLQE-HNNXBMFYSA-N 0.000 claims 1
- UMUOBHUONSSGBG-INIZCTEOSA-N 2-[4-chloro-2-[[(3s)-4-[2-(3-fluoro-4-methylphenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=C(F)C(C)=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O UMUOBHUONSSGBG-INIZCTEOSA-N 0.000 claims 1
- NRJBFDZWXPHYJR-HNNXBMFYSA-N 2-[4-chloro-2-[[(3s)-4-[2-(3-fluorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=C(F)C=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O NRJBFDZWXPHYJR-HNNXBMFYSA-N 0.000 claims 1
- VVYXFODKAOCOFT-AWEZNQCLSA-N 2-[4-chloro-2-[[(3s)-4-[2-(4-chloro-2-fluorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C(=CC(Cl)=CC=2)F)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O VVYXFODKAOCOFT-AWEZNQCLSA-N 0.000 claims 1
- MSSLADGIBICRTQ-INIZCTEOSA-N 2-[4-chloro-2-[[(3s)-4-[2-(4-chlorophenyl)-2-methylpropanoyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)C(C)(C)C=2C=CC(Cl)=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O MSSLADGIBICRTQ-INIZCTEOSA-N 0.000 claims 1
- BHZNGMOMDQDTGT-HNNXBMFYSA-N 2-[4-chloro-2-[[(3s)-4-[2-(4-chlorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC(Cl)=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O BHZNGMOMDQDTGT-HNNXBMFYSA-N 0.000 claims 1
- HETDCNLHSCWGNG-HNNXBMFYSA-N 2-[4-chloro-2-[[(3s)-4-[2-(4-fluorophenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC(F)=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O HETDCNLHSCWGNG-HNNXBMFYSA-N 0.000 claims 1
- UIEALAUEQXQKKJ-INIZCTEOSA-N 2-[4-chloro-2-[[(3s)-4-[2-(4-methoxyphenyl)acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C1=CC(OC)=CC=C1CC(=O)N1[C@@H](C)CN(CC=2C(=CC=C(Cl)C=2)OCC(O)=O)CC1 UIEALAUEQXQKKJ-INIZCTEOSA-N 0.000 claims 1
- KPCVQXUUGXXCCD-AWEZNQCLSA-N 2-[4-chloro-2-[[(3s)-4-[2-[2-fluoro-4-(trifluoromethyl)phenyl]acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C(=CC(=CC=2)C(F)(F)F)F)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O KPCVQXUUGXXCCD-AWEZNQCLSA-N 0.000 claims 1
- DHPMQWCGCDLZMZ-AWEZNQCLSA-N 2-[4-chloro-2-[[(3s)-4-[2-[3-fluoro-4-(trifluoromethyl)phenyl]acetyl]-3-methylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=C(F)C(=CC=2)C(F)(F)F)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O DHPMQWCGCDLZMZ-AWEZNQCLSA-N 0.000 claims 1
- AFHZNYOZSHABDK-CALCHBBNSA-N 2-[4-chloro-2-[[(3s,5r)-3,5-dimethyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N([C@H](C)C1)C(=O)CC=2C=CC=CC=2)C)N1CC1=CC(Cl)=CC=C1OCC(O)=O AFHZNYOZSHABDK-CALCHBBNSA-N 0.000 claims 1
- JTNMVEBSCUDNMB-UHFFFAOYSA-N 2-[4-chloro-2-[[2,5-dimethyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound CC1CN(C(=O)CC=2C=CC=CC=2)C(C)CN1CC1=CC(Cl)=CC=C1OCC(O)=O JTNMVEBSCUDNMB-UHFFFAOYSA-N 0.000 claims 1
- GMFBGMFMMAVODH-UHFFFAOYSA-N 2-[4-chloro-2-[[3-methyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C1CN(C(=O)CC=2C=CC=CC=2)C(C)CN1CC1=CC(Cl)=CC=C1OCC(O)=O GMFBGMFMMAVODH-UHFFFAOYSA-N 0.000 claims 1
- QMELTJDCTLMGCP-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(2-phenylacetyl)-1,4-diazepan-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(C(=O)CC=2C=CC=CC=2)CCC1 QMELTJDCTLMGCP-UHFFFAOYSA-N 0.000 claims 1
- NZMAJXVEGBZEEC-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(2-phenylpropanoyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C=1C=CC=CC=1C(C)C(=O)N(CC1)CCN1CC1=CC(Cl)=CC=C1OCC(O)=O NZMAJXVEGBZEEC-UHFFFAOYSA-N 0.000 claims 1
- LFQMJSQLJKPHCR-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(2-pyridin-3-ylacetyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(C(=O)CC=2C=NC=CC=2)CC1 LFQMJSQLJKPHCR-UHFFFAOYSA-N 0.000 claims 1
- UGHQMGMBAHIYMH-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(3,4-dichlorophenyl)sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=C(Cl)C(Cl)=CC=2)CC1 UGHQMGMBAHIYMH-UHFFFAOYSA-N 0.000 claims 1
- IAPIBKHPGNYMIM-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(3,4-difluorophenyl)sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=C(F)C(F)=CC=2)CC1 IAPIBKHPGNYMIM-UHFFFAOYSA-N 0.000 claims 1
- QMYOIVSLXDKWKJ-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(3-chloro-4-fluorophenyl)sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=C(Cl)C(F)=CC=2)CC1 QMYOIVSLXDKWKJ-UHFFFAOYSA-N 0.000 claims 1
- HFLNBDKNUXVONC-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(3-chlorophenyl)sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=C(Cl)C=CC=2)CC1 HFLNBDKNUXVONC-UHFFFAOYSA-N 0.000 claims 1
- ZCMJPFSXDXFBES-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(3-fluorophenyl)sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=C(F)C=CC=2)CC1 ZCMJPFSXDXFBES-UHFFFAOYSA-N 0.000 claims 1
- HXEHNYOADQYQOC-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(3-phenylpropanoyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(C(=O)CCC=2C=CC=CC=2)CC1 HXEHNYOADQYQOC-UHFFFAOYSA-N 0.000 claims 1
- MJFMIEXSNLSKBA-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(4-chlorophenyl)sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=CC(Cl)=CC=2)CC1 MJFMIEXSNLSKBA-UHFFFAOYSA-N 0.000 claims 1
- YEPKGHKIZDVJEY-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(4-fluorophenyl)sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=CC(F)=CC=2)CC1 YEPKGHKIZDVJEY-UHFFFAOYSA-N 0.000 claims 1
- SVKSSVSQZRWBMW-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(pyridin-2-ylmethylsulfonyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)CC=2N=CC=CC=2)CC1 SVKSSVSQZRWBMW-UHFFFAOYSA-N 0.000 claims 1
- MFNQNQUCCFZGBC-UHFFFAOYSA-N 2-[4-chloro-2-[[4-(pyridin-3-ylmethylsulfonyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)CC=2C=NC=CC=2)CC1 MFNQNQUCCFZGBC-UHFFFAOYSA-N 0.000 claims 1
- HJYFIAQSJJSCJD-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[(2-nitrophenyl)methylsulfonyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)CC=2C(=CC=CC=2)[N+]([O-])=O)CC1 HJYFIAQSJJSCJD-UHFFFAOYSA-N 0.000 claims 1
- TVAOVFSSAKYBGM-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[(3-chlorophenyl)methylsulfonyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)CC=2C=C(Cl)C=CC=2)CC1 TVAOVFSSAKYBGM-UHFFFAOYSA-N 0.000 claims 1
- JQZCNXVAHYQALK-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[(3-methylphenyl)methylsulfonyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound CC1=CC=CC(CS(=O)(=O)N2CCN(CC=3C(=CC=C(Cl)C=3)OCC(O)=O)CC2)=C1 JQZCNXVAHYQALK-UHFFFAOYSA-N 0.000 claims 1
- CWVJXMDXAIQPKJ-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[(4-chlorophenyl)methylsulfonyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)CC=2C=CC(Cl)=CC=2)CC1 CWVJXMDXAIQPKJ-UHFFFAOYSA-N 0.000 claims 1
- QDSPXLFDGHZUJJ-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[(4-fluorophenyl)methylsulfonyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)CC=2C=CC(F)=CC=2)CC1 QDSPXLFDGHZUJJ-UHFFFAOYSA-N 0.000 claims 1
- IOTNAJLLTFNQOL-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[(4-methylphenyl)methylsulfonyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C1=CC(C)=CC=C1CS(=O)(=O)N1CCN(CC=2C(=CC=C(Cl)C=2)OCC(O)=O)CC1 IOTNAJLLTFNQOL-UHFFFAOYSA-N 0.000 claims 1
- ULYCVFZPMWVYCG-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[2-(4-chlorophenyl)acetyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(C(=O)CC=2C=CC(Cl)=CC=2)CC1 ULYCVFZPMWVYCG-UHFFFAOYSA-N 0.000 claims 1
- GESQXXWZMKUSRO-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[2-(4-cyanophenyl)acetyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(C(=O)CC=2C=CC(=CC=2)C#N)CC1 GESQXXWZMKUSRO-UHFFFAOYSA-N 0.000 claims 1
- JKYOGZWGUBGRIF-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[2-(4-fluorophenyl)acetyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(C(=O)CC=2C=CC(F)=CC=2)CC1 JKYOGZWGUBGRIF-UHFFFAOYSA-N 0.000 claims 1
- SYNYMOOIHRQYQN-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[2-(4-methoxyphenyl)acetyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C1=CC(OC)=CC=C1CC(=O)N1CCN(CC=2C(=CC=C(Cl)C=2)OCC(O)=O)CC1 SYNYMOOIHRQYQN-UHFFFAOYSA-N 0.000 claims 1
- YFJRJSADALDRPD-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[2-(4-methylphenyl)acetyl]piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C1=CC(C)=CC=C1CC(=O)N1CCN(CC=2C(=CC=C(Cl)C=2)OCC(O)=O)CC1 YFJRJSADALDRPD-UHFFFAOYSA-N 0.000 claims 1
- CWVWNDSQBGNNDK-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[3-(difluoromethoxy)phenyl]sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=C(OC(F)F)C=CC=2)CC1 CWVWNDSQBGNNDK-UHFFFAOYSA-N 0.000 claims 1
- WIQVWABSIRJASR-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[3-(trifluoromethoxy)phenyl]sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=C(OC(F)(F)F)C=CC=2)CC1 WIQVWABSIRJASR-UHFFFAOYSA-N 0.000 claims 1
- QDMXZTDDAPAHGD-UHFFFAOYSA-N 2-[4-chloro-2-[[4-[3-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCN(S(=O)(=O)C=2C=C(C=CC=2)C(F)(F)F)CC1 QDMXZTDDAPAHGD-UHFFFAOYSA-N 0.000 claims 1
- SKIALVHXEPTEDB-KRWDZBQOSA-N 2-[4-cyano-2-[[(3s)-3-methyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC=CC=2)C)N1CC1=CC(C#N)=CC=C1OCC(O)=O SKIALVHXEPTEDB-KRWDZBQOSA-N 0.000 claims 1
- IAQXQPWNIYKQDL-SFHVURJKSA-N 2-[4-methyl-2-[[(3s)-3-methyl-4-(2-phenylacetyl)piperazin-1-yl]methyl]phenoxy]acetic acid Chemical compound C([C@@H](N(CC1)C(=O)CC=2C=CC=CC=2)C)N1CC1=CC(C)=CC=C1OCC(O)=O IAQXQPWNIYKQDL-SFHVURJKSA-N 0.000 claims 1
- NUUKCZHOQCNSMN-UHFFFAOYSA-N 2-[6-chloro-6-[[4-[2-(4-chlorophenyl)acetyl]piperazin-1-yl]methyl]cyclohexa-2,4-dien-1-yl]oxyacetic acid Chemical compound OC(=O)COC1C=CC=CC1(Cl)CN1CCN(C(=O)CC=2C=CC(Cl)=CC=2)CC1 NUUKCZHOQCNSMN-UHFFFAOYSA-N 0.000 claims 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- BDIIXJCOXLQTKD-UHFFFAOYSA-N azetidin-1-amine Chemical compound NN1CCC1 BDIIXJCOXLQTKD-UHFFFAOYSA-N 0.000 claims 1
- 150000004985 diamines Chemical class 0.000 claims 1
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 claims 1
- LWMPFIOTEAXAGV-UHFFFAOYSA-N piperidin-1-amine Chemical compound NN1CCCCC1 LWMPFIOTEAXAGV-UHFFFAOYSA-N 0.000 claims 1
- 150000003053 piperidines Chemical class 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 claims 1
- BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 claims 1
- SBMSLRMNBSMKQC-UHFFFAOYSA-N pyrrolidin-1-amine Chemical compound NN1CCCC1 SBMSLRMNBSMKQC-UHFFFAOYSA-N 0.000 claims 1
- 208000023504 respiratory system disease Diseases 0.000 claims 1
- 206010039083 rhinitis Diseases 0.000 claims 1
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000003480 eluent Substances 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- VXVIICNFYDEOJG-UHFFFAOYSA-N 2-(4-chloro-2-formylphenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1C=O VXVIICNFYDEOJG-UHFFFAOYSA-N 0.000 description 1
- GGXHNHALEKSOAT-UHFFFAOYSA-N 2-(4-chloro-2-piperazin-1-ylphenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1N1CCNCC1 GGXHNHALEKSOAT-UHFFFAOYSA-N 0.000 description 1
- ZOUYZUHVCHDANN-UHFFFAOYSA-N 2-[4-chloro-2-(piperazin-1-ylmethyl)phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=C(Cl)C=C1CN1CCNCC1 ZOUYZUHVCHDANN-UHFFFAOYSA-N 0.000 description 1
- SCSOMGCOVHWJII-UHFFFAOYSA-N C(C)(=O)OCCOC1=C(C=C(C=C1)C(C)C)CN1CCN(CC1)S(=O)(=O)C1=CC=CC=C1 Chemical compound C(C)(=O)OCCOC1=C(C=C(C=C1)C(C)C)CN1CCN(CC1)S(=O)(=O)C1=CC=CC=C1 SCSOMGCOVHWJII-UHFFFAOYSA-N 0.000 description 1
- CXXJTVTWGNPCLD-UHFFFAOYSA-L C([O-])([O-])=O.[K+].C(=O)C1=C(OCC(=O)O)C=CC(=C1)C(F)(F)F.[K+] Chemical compound C([O-])([O-])=O.[K+].C(=O)C1=C(OCC(=O)O)C=CC(=C1)C(F)(F)F.[K+] CXXJTVTWGNPCLD-UHFFFAOYSA-L 0.000 description 1
- YVCIXOUQKBWCPW-UHFFFAOYSA-N Cl.OC1=CC=C(Cl)C=C1N1CCNCC1.COC1=CC=C(Cl)C=C1N1CCNCC1 Chemical compound Cl.OC1=CC=C(Cl)C=C1N1CCNCC1.COC1=CC=C(Cl)C=C1N1CCNCC1 YVCIXOUQKBWCPW-UHFFFAOYSA-N 0.000 description 1
- VEDPQGGGGHKSLY-UHFFFAOYSA-N OC(COc(c(CN(CC1)CCN1S(c1ccccc1)(=O)=O)c1)ccc1Cl)=O Chemical compound OC(COc(c(CN(CC1)CCN1S(c1ccccc1)(=O)=O)c1)ccc1Cl)=O VEDPQGGGGHKSLY-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- RCBWGBZOCSJUEI-UHFFFAOYSA-N [1-(benzenesulfonyl)pyrrolidin-3-yl]-methylcarbamic acid Chemical compound C1C(N(C)C(O)=O)CCN1S(=O)(=O)C1=CC=CC=C1 RCBWGBZOCSJUEI-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- FMLPQHJYUZTHQS-QMMMGPOBSA-N tert-butyl (3s)-3-methylpiperazine-1-carboxylate Chemical compound C[C@H]1CN(C(=O)OC(C)(C)C)CCN1 FMLPQHJYUZTHQS-QMMMGPOBSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0425673.1 | 2004-11-23 | ||
| GB0425673A GB0425673D0 (en) | 2004-11-23 | 2004-11-23 | Novel compounds |
| GB0508923.0 | 2005-04-30 | ||
| GB0508923A GB0508923D0 (en) | 2005-04-30 | 2005-04-30 | Novel compounds |
| PCT/GB2005/004464 WO2006056752A1 (en) | 2004-11-23 | 2005-11-22 | Phenoxyacetic acid derivatives useful for treating respiratory diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012280027A Division JP2013082729A (ja) | 2004-11-23 | 2012-12-21 | 呼吸器疾患の処置に有用なフェノキシ酢酸誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008520637A JP2008520637A (ja) | 2008-06-19 |
| JP2008520637A5 true JP2008520637A5 (https=) | 2009-01-15 |
| JP5208510B2 JP5208510B2 (ja) | 2013-06-12 |
Family
ID=35589515
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007542103A Expired - Fee Related JP5208510B2 (ja) | 2004-11-23 | 2005-11-22 | 呼吸器疾患の処置に有用なフェノキシ酢酸誘導体 |
| JP2012280027A Pending JP2013082729A (ja) | 2004-11-23 | 2012-12-21 | 呼吸器疾患の処置に有用なフェノキシ酢酸誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012280027A Pending JP2013082729A (ja) | 2004-11-23 | 2012-12-21 | 呼吸器疾患の処置に有用なフェノキシ酢酸誘導体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8524715B2 (https=) |
| EP (1) | EP1817282B1 (https=) |
| JP (2) | JP5208510B2 (https=) |
| AR (1) | AR051966A1 (https=) |
| AT (1) | ATE517085T1 (https=) |
| CY (1) | CY1112115T1 (https=) |
| DK (1) | DK1817282T3 (https=) |
| PL (1) | PL1817282T3 (https=) |
| PT (1) | PT1817282E (https=) |
| SA (1) | SA05260362B1 (https=) |
| SI (1) | SI1817282T1 (https=) |
| TW (1) | TW200630336A (https=) |
| UY (1) | UY29223A1 (https=) |
| WO (1) | WO2006056752A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0301009D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| SE0301010D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| SA04250253B1 (ar) * | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن |
| GB0415320D0 (en) * | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| GB0418830D0 (en) | 2004-08-24 | 2004-09-22 | Astrazeneca Ab | Novel compounds |
| GB0422057D0 (en) * | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
| JP5208510B2 (ja) | 2004-11-23 | 2013-06-12 | アストラゼネカ・アクチエボラーグ | 呼吸器疾患の処置に有用なフェノキシ酢酸誘導体 |
| AU2006296004B2 (en) | 2005-09-27 | 2011-11-17 | Shionogi & Co., Ltd. | Sulfonamide derivative having PGD2 receptor antagonistic activity |
| EA015358B1 (ru) * | 2005-09-30 | 2011-06-30 | Пульмаджен Терапьютикс (Эсме) Лимитед | Хинолины и их терапевтическое применение |
| US8148572B2 (en) | 2005-10-06 | 2012-04-03 | Astrazeneca Ab | Compounds |
| TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| WO2007052023A2 (en) * | 2005-11-05 | 2007-05-10 | Astrazeneca Ab | Novel compounds |
| ATE545637T1 (de) * | 2005-12-15 | 2012-03-15 | Astrazeneca Ab | Substituierte diphenylether, -amine, -sulfide und methane zur behandlung von atemwegserkrankungen |
| UA100983C2 (ru) * | 2007-07-05 | 2013-02-25 | Астразенека Аб | Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты |
| PT2229358E (pt) | 2007-12-14 | 2011-06-29 | Pulmagen Therapeutics Asthma Ltd | Indoles e sua utilização terapêutica |
| AU2009324679A1 (en) * | 2008-12-09 | 2011-07-28 | University Of Florida Research Foundation, Inc. | Kinase inhibitor compounds |
| EP2376435A2 (en) | 2009-01-14 | 2011-10-19 | Dow AgroSciences LLC | Synergistic fungicidal compositions including hydrazone derivatives and copper |
| EP2590944B1 (en) | 2010-07-05 | 2015-09-30 | Actelion Pharmaceuticals Ltd. | 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
| EP2790696A1 (en) | 2011-12-16 | 2014-10-22 | Atopix Therapeutics Limited | Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis |
| JP6097765B2 (ja) | 2011-12-21 | 2017-03-15 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | ヘテロシクリル誘導体及びプロスタグランジンｄ２受容体調節剤としてのそれらの使用 |
| WO2014006585A1 (en) | 2012-07-05 | 2014-01-09 | Actelion Pharmaceuticals Ltd | 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| EP3288527B1 (en) | 2015-04-28 | 2020-02-19 | Unilever PLC, a company registered in England and Wales under company no. 41424 of | N-aralkylcarbonyldiamine compounds and personal care compositions comprising the same |
| US10155733B2 (en) | 2015-04-28 | 2018-12-18 | Conopco, Inc. | N-aralkylcarbonyl-piperazine and -homopiperazine compounds and personal care compositions comprising the same |
| WO2017209272A1 (ja) * | 2016-06-03 | 2017-12-07 | 国立大学法人東京大学 | がん転移阻害剤 |
| WO2020254559A1 (en) | 2019-06-19 | 2020-12-24 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
Family Cites Families (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB690816A (en) | 1950-01-02 | 1953-04-29 | British Drug Houses Ltd | Improvements in or relating to the manufacture of substituted phenoxy acetic acids |
| US3278524A (en) | 1962-03-13 | 1966-10-11 | Beecham Group Ltd | Penicillins and their production |
| CH432119A (de) | 1963-02-22 | 1967-03-15 | Geigy Ag J R | Verwendung von Halogen-o-hydroxy-diphenyläthern als antimikrobielle Mittel |
| BE790679A (fr) | 1971-11-03 | 1973-04-27 | Ici Ltd | Derives de l'indole |
| DD113545A5 (https=) | 1973-03-30 | 1975-06-12 | ||
| JPS5239888B2 (https=) | 1973-05-28 | 1977-10-07 | ||
| ES431425A1 (es) | 1973-10-29 | 1977-01-16 | Eisai Co Ltd | Un procedimiento para la preparacion de derivados del acido 2-(m-fenoxifenil)-propionico. |
| CH582476A5 (https=) | 1973-10-29 | 1976-12-15 | Ciba Geigy Ag | |
| GB1585963A (en) | 1976-10-14 | 1981-03-11 | Lilly Industries Ltd | Aryl sulphur compounds |
| US4248618A (en) | 1977-05-06 | 1981-02-03 | Ici Australia Limited | Derivatives of (pyrimidyloxy)phenoxy-alkanecarboxylic acid and herbicidal compositions thereof |
| FR2428629A1 (fr) | 1978-06-14 | 1980-01-11 | Hexachimie | Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique |
| JPS5951943B2 (ja) | 1978-08-21 | 1984-12-17 | キツセイ薬品工業株式会社 | 新規なイミダゾ−ル誘導体 |
| GB2041363B (en) | 1979-01-19 | 1982-10-06 | Pfizer Ltd | N-benzyl-imidazoles |
| US4670566A (en) | 1979-07-12 | 1987-06-02 | A. H. Robins Company, Incorporated | 3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones |
| US4486593A (en) | 1983-01-19 | 1984-12-04 | The Upjohn Company | 2-,3-, or 4-Pyridinylmethylamino arylic acids as thromboxane A2 synthetase and 5-lipoxygenase inhibitors |
| US5006542A (en) | 1988-10-31 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use |
| US5145790A (en) | 1990-05-04 | 1992-09-08 | Abbott Laboratories | Reagents and method for detecting polychlorinated biphenyls |
| EP0540165A1 (en) | 1991-10-03 | 1993-05-05 | Zeneca Limited | Alkanoic acid derivatives |
| WO1993012086A1 (fr) * | 1991-12-11 | 1993-06-24 | Ss Pharmaceutical Co., Ltd. | Derive d'arylamide |
| CA2090283A1 (en) | 1992-02-28 | 1993-08-29 | Nobuyuki Hamanaka | Phenoxyacetic acid derivatives |
| CA2110095A1 (en) * | 1992-12-08 | 1994-06-09 | Teruo Komoto | Arylamide derivatives |
| JP2825755B2 (ja) * | 1993-04-07 | 1998-11-18 | 大塚製薬株式会社 | ピペリジン誘導体を有効成分とする末梢血管拡張剤および新規ピペリジン誘導体 |
| JPH06313995A (ja) | 1993-04-28 | 1994-11-08 | Hodogaya Chem Co Ltd | 静電荷像現像用トナー |
| US5489412A (en) | 1993-04-30 | 1996-02-06 | Kabushiki Kaisha Meidensha | Electrode material |
| JPH07140725A (ja) | 1993-06-25 | 1995-06-02 | Hodogaya Chem Co Ltd | 負帯電性トナー用摩擦帯電付与部材 |
| US5612353A (en) * | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
| EP0847379A1 (en) | 1995-08-28 | 1998-06-17 | American Home Products Corporation | Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents |
| ES2194209T3 (es) | 1996-07-22 | 2003-11-16 | Monsanto Co | Inhibidores de metaloproteasa de tiol sulfona. |
| CA2219269A1 (en) | 1996-10-29 | 1998-04-29 | Novartis Ag | Novel herbicides |
| FR2763588B1 (fr) | 1997-05-23 | 1999-07-09 | Cird Galderma | Composes triaromatiques, compositions les contenant et utilisations |
| CO4960662A1 (es) | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
| US5942532A (en) | 1997-09-05 | 1999-08-24 | Ortho Pharmaceutical Corporation | 2-substituted phenyl-benzimidazole antibacterial agents |
| ES2226167T3 (es) | 1997-09-12 | 2005-03-16 | MERCK FROSST CANADA & CO. | Piridinas 2,3,5-sustituidas como inhibidores de ciclooxigenasa 2. |
| WO1999019291A1 (en) | 1997-10-14 | 1999-04-22 | Asahi Kasei Kogyo Kabushiki Kaisha | Biphenyl-5-alkanoic acid derivatives and use thereof |
| JP3486408B2 (ja) | 1999-08-23 | 2004-01-13 | 株式会社ビー・エム・エル | 物質のヒトプロスタグランジンｄ２受容体に対する性質の同定方法 |
| SE9902987D0 (sv) * | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
| DE60005973T2 (de) | 1999-08-27 | 2004-05-13 | Eli Lilly And Co., Indianapolis | Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren |
| AU784722B2 (en) | 2000-02-18 | 2006-06-01 | Merck & Co., Inc. | Aryloxyacetic acids for diabetes and lipid disorders |
| EP1278734A2 (en) | 2000-04-24 | 2003-01-29 | Merck Frosst Canada & Co. | Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| NZ522074A (en) | 2000-05-31 | 2004-06-25 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| JP2004501191A (ja) * | 2000-06-28 | 2004-01-15 | テバ ファーマシューティカル インダストリーズ リミティド | カルベジロール |
| US6878522B2 (en) | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| US20040097555A1 (en) | 2000-12-26 | 2004-05-20 | Shinegori Ohkawa | Concomitant drugs |
| BR0210391A (pt) * | 2001-06-12 | 2004-06-15 | Elan Pharm Inc | Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto |
| CA2473803A1 (en) | 2002-02-01 | 2003-08-07 | Robert Greenhouse | Substituted indoles as alpha-1 agonists |
| SE0200411D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| WO2003068744A1 (en) | 2002-02-18 | 2003-08-21 | Ishihara Sangyo Kaisha, Ltd. | Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same |
| CA2479338A1 (en) | 2002-03-20 | 2003-10-02 | Metabolex, Inc. | Substituted phenylacetic acids |
| AU2003231513A1 (en) | 2002-05-16 | 2003-12-02 | Shionogi And Co., Ltd. | Pgd2 receptor antagonist |
| EP2423190A1 (en) | 2002-05-16 | 2012-02-29 | Shionogi&Co., Ltd. | Compounds Exhibiting PGD 2 Receptor Antagonism |
| SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
| SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
| US7119200B2 (en) * | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| PE20040844A1 (es) | 2002-11-26 | 2004-12-30 | Novartis Ag | Acidos fenilaceticos y derivados como inhibidores de la cox-2 |
| WO2004052862A1 (ja) * | 2002-12-10 | 2004-06-24 | Ono Pharmaceutical Co., Ltd. | 含窒素複素環化合物およびその医薬用途 |
| ZA200505523B (en) | 2002-12-20 | 2006-09-27 | Amgen Inc | Asthma and allergic inflammation modulators |
| US7414063B2 (en) | 2003-03-28 | 2008-08-19 | Eli Lilly And Company | Inhibitors of Akt (protein kinase B) |
| JP2004315511A (ja) * | 2003-03-31 | 2004-11-11 | Taisho Pharmaceut Co Ltd | Ｍｃｈ受容体アンタゴニスト |
| SE0301010D0 (sv) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| SE0301009D0 (sv) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| DE60303238T2 (de) | 2003-04-25 | 2006-09-14 | Actimis Pharmaceuticals, Inc., La Jolla | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten |
| SA04250253B1 (ar) | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن |
| GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| US7166738B2 (en) | 2004-04-23 | 2007-01-23 | Roche Palo Alto Llc | Non-nucleoside reverse transcriptase inhibitors |
| GB0409921D0 (en) | 2004-05-04 | 2004-06-09 | Novartis Ag | Organic compounds |
| BRPI0511676A (pt) * | 2004-05-29 | 2008-01-08 | 7Tm Pharma As | uso medicinal de ligandos receptores |
| GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| GB0418830D0 (en) | 2004-08-24 | 2004-09-22 | Astrazeneca Ab | Novel compounds |
| GB0422057D0 (en) | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
| JP5208510B2 (ja) * | 2004-11-23 | 2013-06-12 | アストラゼネカ・アクチエボラーグ | 呼吸器疾患の処置に有用なフェノキシ酢酸誘導体 |
| GB0510584D0 (en) | 2005-05-24 | 2005-06-29 | Novartis Ag | Organic compounds |
| US8148572B2 (en) | 2005-10-06 | 2012-04-03 | Astrazeneca Ab | Compounds |
| TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| WO2007052023A2 (en) | 2005-11-05 | 2007-05-10 | Astrazeneca Ab | Novel compounds |
| ATE545637T1 (de) | 2005-12-15 | 2012-03-15 | Astrazeneca Ab | Substituierte diphenylether, -amine, -sulfide und methane zur behandlung von atemwegserkrankungen |
| UA100983C2 (ru) | 2007-07-05 | 2013-02-25 | Астразенека Аб | Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты |
-
2005
- 2005-11-22 JP JP2007542103A patent/JP5208510B2/ja not_active Expired - Fee Related
- 2005-11-22 US US11/719,832 patent/US8524715B2/en not_active Expired - Fee Related
- 2005-11-22 AR ARP050104896A patent/AR051966A1/es unknown
- 2005-11-22 DK DK05807437.8T patent/DK1817282T3/da active
- 2005-11-22 AT AT05807437T patent/ATE517085T1/de active
- 2005-11-22 PL PL05807437T patent/PL1817282T3/pl unknown
- 2005-11-22 EP EP05807437A patent/EP1817282B1/en not_active Expired - Lifetime
- 2005-11-22 SI SI200531361T patent/SI1817282T1/sl unknown
- 2005-11-22 UY UY29223A patent/UY29223A1/es not_active Application Discontinuation
- 2005-11-22 WO PCT/GB2005/004464 patent/WO2006056752A1/en not_active Ceased
- 2005-11-22 PT PT05807437T patent/PT1817282E/pt unknown
- 2005-11-23 TW TW094141046A patent/TW200630336A/zh unknown
- 2005-11-23 SA SA05260362A patent/SA05260362B1/ar unknown
-
2011
- 2011-09-15 CY CY20111100891T patent/CY1112115T1/el unknown
-
2012
- 2012-12-21 JP JP2012280027A patent/JP2013082729A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008520637A5 (https=) | ||
| RU2354653C2 (ru) | Производные 1-(2-аминобензол)пиперазина, используемые в качестве ингибиторов поглощения глицина и предназначенные для лечения психоза | |
| KR101574905B1 (ko) | 피라졸 유도체 | |
| AU2003290280A1 (en) | 4, 5-diarylthiazole derivatives as cb-1 ligands | |
| JP2003532730A (ja) | 細胞増殖抑制剤として有用な１，１−ジオキソイソチアゾリジンを持つインダゾール | |
| AU782191B2 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
| JP5167241B2 (ja) | 癌の処置用のヒストンデアセチラーゼ阻害剤としての、ｎ−ヒドロキシ−３−（４−｛３−フェニル−ｓ−オキソ−プロペニル｝−フェニル）−アクリルアミド誘導体及びその関連化合物 | |
| WO2000032582A1 (en) | Benzamide derivatives and their use as apob-100 secretion inhibitors | |
| JPWO2005037269A1 (ja) | 新規ピペリジン誘導体 | |
| JP2007519754A5 (https=) | ||
| JP2009539762A (ja) | Ｈ３受容体のテトラリン拮抗薬 | |
| JP2005508923A5 (https=) | ||
| EP3022202A1 (en) | Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core | |
| MXPA05006919A (es) | Derivados de 1,5-diaril-pirrol-3-carboxamida y su uso como moduladores del receptor canabinoide. | |
| RU2012156925A (ru) | Соединения пиразола в качестве ингибиторов сигма рецепторов | |
| JP2007511485A (ja) | Ｐｐａｒアゴニストとしての置換ピラゾール | |
| JP2010509280A (ja) | シグマ受容体阻害剤としての１，２，４−トリアゾール誘導体 | |
| WO2001096327A1 (en) | BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS | |
| RU2394028C2 (ru) | Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы | |
| EA018995B1 (ru) | Производные карбаматов алкилтиазолов, их получение и их применение в терапии | |
| KR100909953B1 (ko) | 항진균 활성을 갖는 트라이아졸 유도체, 이의 제조방법 및이를 함유하는 약학 조성물 | |
| JP4796046B2 (ja) | ピペリジニルアルキルカーバメートの誘導体、これらの製造方法及びｆａａｈ酵素インヒビターとしての使用 | |
| JP2004507527A5 (https=) | ||
| CN110698432B (zh) | 苯甲基哌嗪类化合物及其制备方法和在抗病毒中的应用 | |
| WO1986004581A1 (en) | Dihydropyridine alkanolamines |